The success of Silicon Valley is often attributed to the ability of the entrepreneurial community to embrace setbacks rather than punishing those who experience them. Celebrating these setbacks has become an art form of it own as a recent NYT [See the full post…]

The gap between the promise and practice of technology has been especially vivid in the area of pharmaceutical clinical trials, where even switching from paper to electronic data capture has proved too radical for some sponsors. Today’s guest, Kara Dennis, [See the full post…]

James Joyce, the famous Irish author once said, “A man of genius makes no mistakes. His errors are volitional and are the portraits of discovery.” His namesake, entrepreneur Jim Joyce, could not agree more. An entrepreneur many times over and [See the full post…]

For years, medical research seemed focused on understanding disease processes primarily through model organisms such as yeast, flies, and mice. Today’s guest, Merck’s Robert Plenge, offers the radical suggestion that with the help of emerging technology “humans serve as the [See the full post…]